AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

ATEC · NASDAQ · Medical - Devices

Alphatec (ATEC)

Builds spine-focused surgical implants, imaging, and procedural software for spine disorder treatment.

$10.38

After hours+0.06 (+0.58%)

At close$10.32(+1.47%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	118	138	138	146	151	177	169	186	197	213	192	214
Cost of revenue	38	43	41	43	48	55	53	56	59	83	75	59
Gross profit	80	95	97	103	103	122	116	129	137	130	117	154
	118	140	141	138	136	145	160	142	153	136	139	156
Research & development	20	22	18	19	20	23	17	18	19	23	18	18
Selling, general & administrative	91	104	114	113	109	115	127	119	124	113	137	134
Other expenses	7	14	9	6	7	8	17	5	10	0	−15	4
Operating income	−38	−45	−43	−35	−34	−24	−44	−13	−16	−5	−22	−2
	−4	−4	−5	−6	−6	−9	−8	−28	−13	−16	−12	−24
Interest expense	4	4	5	6	7	7	8	12	13	5	12	11
Other non-operating income	0	0	0	0	−1	2	0	16	0	11	0	13
Income before tax	−43	−49	−49	−41	−40	−33	−52	−41	−29	−22	−34	−26
Income tax expense	0	0	0	0	0	0	0	0	0	0	0	0
Net income from continuing operations	−43	−49	−48	−41	−40	−33	−52	−41	−29	−22	−34	−26
Net income	−43	−49	−48	−41	−40	−33	−52	−41	−29	−22	−34	−26
EPS, basic	−$0.35	−$0.37	−$0.34	−$0.29	−$0.28	−$0.23	−$0.35	−$0.27	−$0.19	−$0.15	−$0.22	−$0.16
EPS, diluted	−$0.35	−$0.37	−$0.34	−$0.29	−$0.28	−$0.23	−$0.35	−$0.27	−$0.19	−$0.15	−$0.22	−$0.16
Weighted average shares, basic	122	134	141	143	143	143	147	150	151	150	154	155
Weighted average shares, diluted	122	134	141	143	143	143	147	150	151	150	154	155
EBITDA	−23	−28	−24	−14	−11	−4	−23	−8	5	4	−2	6
Depreciation & amortization	16	17	19	21	22	21	21	21	20	20	20	21
EBIT	−38	−45	−43	−35	−33	−26	−44	−29	−16	−17	−22	−15